The Rebound in Fitness Startup Funding Is Real—and Narrow
Investment into fitness and wellness startups is climbing again, but the rebound looks different from the pandemic-era boom. Crunchbase data puts first-half 2026 funding at more than $3.6 billion, putting the year on pace to finish roughly a third above 2025. The caveat is that 2025 was the lowest annual total for wellness-related startup funding in at least six years, so the recovery is from a depressed base and is concentrated in a smaller number of large rounds.
Whoop's $575 million Series G in March was the standout deal. Other large fundings included Devoted Health's $366 million Series F and Solace's $130 million Series C. The activity marks a shift away from connected fitness hardware names such as Tonal and Hydrow, which raised hundreds of millions during the peak and have not received new investment in more than three years.
In their place, investors are backing companies that combine continuous health data collection with AI-driven personalization: Eight Sleep raised $50 million in March, Ultrahuman about $44 million in February, and New Delhi-based Temple raised a $54 million seed for a brain-focused wearable that tracks cerebral blood flow and energy expenditure.
The report suggests the sector may see more consolidation through acquisitions or private equity roll-ups rather than a broad IPO wave, with Crunchbase identifying Whoop, Oura, Spring Health and Fountain Life as likely IPO candidates.
Why Investors Are Backing Health Data and AI Over Treadmills
From Tonal and Hydrow to Whoop and Eight Sleep: A Hardware Reset
The funding recovery is not a return to expensive home fitness machines. Tonal and Hydrow have now gone more than three years without fresh equity, despite having raised hundreds of millions during the boom. By contrast, Whoop, Eight Sleep and Ultrahuman raised large rounds in early 2026. The pattern suggests investors are willing to fund hardware only when it functions as a data-collection layer with recurring software or healthcare potential, not as a standalone device purchase.
Why AI and Proprietary Data Are the New Pitch
The common thread is continuous, defensible data. Whoop's wearable generates physiological data; Temple claims to track cerebral blood flow and uses a proprietary Entropy measure to quantify energy expenditure. That gives the companies a basis for AI personalization and, potentially, a service or healthcare revenue model beyond device margins. The strategic logic is that recurring software and health insights create more durable value than one-time hardware sales.
Consolidation, Not a Rush of IPOs
The report expects more M&A and private equity roll-ups, following Strava's purchase of Runna and Garmin's acquisition of TrainingPeaks. That points to strategic buyers paying for training data, software and community engagement. A broad IPO wave is unlikely; Crunchbase names Whoop, Oura, Spring Health and Fountain Life as the possible exceptions, reflecting investor preference for proven, high-profile platform assets rather than smaller hardware plays.
What the Shift Means for Founders, Investors and Hardware Holdouts
For Founders and Investors in Fitness Tech
- Anchor hardware in a data or software layer. Temple's $54 million seed and Whoop's $575 million Series G show demand for devices that feed AI-driven health insight, while Tonal and Hydrow have not raised new equity in over three years, making a pure device pitch a harder sell.
- Look for acquisition-ready fitness data platforms. Strategic buyers are active: Strava acquired Runna and Garmin acquired TrainingPeaks. Founders and investors should assess whether a platform's dataset or community is complementary to a larger fitness or health company.
- Keep IPO expectations narrow. Crunchbase identifies Whoop, Oura, Spring Health and Fountain Life as likely IPO candidates, but the overall sector is expected to consolidate rather than produce a broad wave of public offerings.
Risk & Opportunity Assessment
| Commercial Risk | Medium | The rebound is concentrated in fewer, larger deals, leaving pandemic-era connected hardware makers such as Tonal and Hydrow without fresh equity for more than three years while data/AI wearables attract capital. |
| Competitive Risk | High | Funding is consolidating around platform-scale players such as Whoop, Eight Sleep and Ultrahuman, raising the bar for new entrants to compete for AI-driven wellness data and proprietary health insights. |
| Regulatory Risk | Low | The article identifies no immediate regulatory action; the main exposure is future scrutiny of health data collection and AI-driven wellness claims, which is not yet specified in the funding data. |
| Reputation Risk | Medium | As investors reward AI and data claims, companies that overstate device accuracy or health outcomes could face credibility damage; Temple and other startups are marketing proprietary measures such as Entropy, which are still unproven at scale. |
| Technology Disruption | High | AI-driven personalization and continuous health monitoring are displacing standalone connected fitness hardware, shown by the funding shift from Tonal and Hydrow to Whoop, Eight Sleep, Ultrahuman and Temple. |
| Commercial Opportunity | High | Investors are writing large checks for the data/AI wellness layer, including Whoop's $575 million round and Temple's $54 million seed, and strategic buyers such as Strava and Garmin have already acquired complementary platforms. |
Comments 0